Firebrick Pharma secures Nasodine approval in Indonesia
Firebrick Pharma (ASX:FRE) has secured its first-ever regulatory approval for Nasodine nasal spray.
Todas as matérias desta categoria, das mais recentes às mais antigas.
Firebrick Pharma (ASX:FRE) has secured its first-ever regulatory approval for Nasodine nasal spray.
Monash IVF Group (ASX:MVF) has appointed Birol Akdogan as its Interim CFO, effective March 26.
Clarity Pharmaceuticals (ASX:CU6) has entered into a large-scale manufacturing supply agreement with Theragenics for the production of copper-64.
Melbourne-based 4DMedical (ASX:4DX) announced the deployment of its CT:VQ technology at the Mayo Clinic.
Recce Pharmaceuticals (ASX:RCE) has been granted a Family 4 patent for its proprietary synthetic anti-infectives.
Echo IQ (ASX: EIQ) announced an expanded agreement to distribute its AI-driven heart failure solution, EchoSolv HF.
Cyclopharm (ASX:CYC) announced a new multi-site agreement with Northwestern Memorial HealthCare, a premier academic health system based in Chicago.
Radiopharm Theranostics (ASX:RAD) said its novel imaging agent, RAD 101, achieved its primary endpoint in 90% of patients during a Phase 2b interim analysis.
Melbourne-based Amplia Therapeutics (ASX:ATX) announced a clinical breakthrough in the treatment of advanced pancreatic cancer.
Enlitic (ASX:ENL) announced the signing of a data migration contract valued at US$1.5 million with Penn Medicine Doylestown Health.
Nexsen (ASX:NXN) completed a pre-submission meeting with the US Food and Drug Administration.
Paradigm Biopharmaceuticals (ASX:PAR) has bolstered its international clinical presence with the activation of a new trial site in Hong Kong.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade